How It Works & Average
Weight Loss
Long-term weight management requires more than temporary solutions. Advances in medical care now support targeted therapies that address appetite regulation, blood sugar response, and metabolic signaling together
Zepbound® offers a new option for adults seeking structured medical weight loss under physician guidance. At Worthy Weight Loss, our practice uses Zepbound® as part of a personalized plan that fits individual health goals, history, and lifestyle needs.
Zepbound® (Tirzepatide) Medical Weight Loss Explained
Zepbound® contains tirzepatide, a once-weekly injectable medication designed for chronic weight management in adults with obesity or overweight. The medication works alongside nutrition and activity changes rather than replacing them. Treatment focuses on appetite control, improved metabolic response, and reduced calorie intake over time.
The FDA approved Zepbound® in November 2023 for chronic weight management. A later FDA approval expanded its use to adults with obesity and moderate to severe obstructive sleep apnea when paired with a reduced-calorie eating plan and physical activity.
Zepbound® shares the same active ingredient as Mounjaro®, which received FDA approval for the treatment of type 2 diabetes in 2022. Both medications follow the same dose progression and are manufactured by Eli Lilly. Indications differ, yet the mechanism of action remains consistent.
What Zepbound® (Tirzepatide) Is and How It Works in the Body
Zepbound® targets two hormone receptors involved in appetite and glucose control:
This dual action helps reduce hunger signals, slows stomach emptying, and improves insulin response after meals. Many patients notice earlier fullness, fewer cravings, and steadier energy levels. The combined receptor approach separates Zepbound® from single-hormone medications such as Saxenda® and Wegovy®.
FDA Approval Status of Zepbound®
The FDA approval covers:
Both approvals require use with lifestyle changes rather than medication alone.
Who May Qualify for Zepbound® Treatment
Adults aged 18 and older may qualify if one or more of the following apply ;
A full medical evaluation guides final eligibility.
Zepbound® Dosage and How It Is Taken
Zepbound® uses a weekly subcutaneous injection. Treatment begins at a low dose to support adjustment, followed by gradual increases as tolerated.
Available dose levels include:
Dose progression depends on response and side effect profile.
Expected Weight Loss Outcomes With Zepbound®
Clinical trials reported average weight loss between 15% and 21% of total body weight. Results vary based on dose, consistency, and lifestyle habits. In our medical weight loss programs, some patients achieved reductions approaching 28% When Treatment Is Aligned [With] Nutrition guidance and activity planning.
Additional benefits may include improvements in:
How Long Zepbound® Is Typically Used
Zepbound® supports long-term weight management. Many patients remain on treatment for several months or longer under medical supervision. Duration depends on results, tolerance, and health goals rather than a predetermined timeline.
Lifestyle Factors That Help Zepbound® Work Better
Medication works best with consistent daily habits such as:
Contact us to talk about ZEPBOUND® and medical weight loss today.
